Stable inhibition of ALYREF by ALYREF shRNA (lanes 6–10, Fig. 3c) in cycloheximide-treated, MYCN-amplified neuroblastoma cells reduced MYCN protein half-life from 36–40 to 14–15 min (Fig. 3c, d). This evidence concerns the gene MYCN and neuroblastoma.